期刊
HEALTH AFFAIRS
卷 28, 期 1, 页码 W125-W137出版社
PROJECT HOPE
DOI: 10.1377/hlthaff.28.1.w125
关键词
-
资金
- NIA NIH HHS [1P30AG24968-01, P30 AG024968] Funding Source: Medline
- NATIONAL INSTITUTE ON AGING [P30AG024968] Funding Source: NIH RePORTER
We describe pharmaceutical regulations in nineteen developed countries from 1992 to 2004 and analyze how different regulations affect pharmaceutical revenues. First, there has been a trend toward increased regulation. Second, most regulations reduce pharmaceutical revenues significantly. Third, since 1994, most countries adopting new regulations already had some regulation in place. We find that incremental regulation of this kind had a smaller impact on costs. However, introducing new regulations in a largely unregulated market, such as the United States, could greatly reduce pharmaceutical revenues. Finally, we show that the cost-reducing effects of price controls increase the longer they remain in place. [Health Affairs 28, no. 1 (2009): w125-w137 (published online 16 December 2008; 10.1377/hlthaff.28.1.w125)]
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据